Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2012
06/27/2012CN101928270B Isobenzofuranone compound, preparation method thereof and use thereof
06/27/2012CN101870725B MAGE (Melanoma Antigen Gene)-4 anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof
06/27/2012CN101869604B Preparation method and application of cortex meliae effective ingredients
06/27/2012CN101857572B 4-aromatic amino pyrimidine derivative and application thereof
06/27/2012CN101856375B Preparation method and application of effective component of trumpetcreeper
06/27/2012CN101838650B Development and applications of new human gene FAMLF in human gene recombination, malignant tumor gene detection and specific monoclonal antibody
06/27/2012CN101836976B Application of icaritin in preparation of anti-angiogenic medicaments
06/27/2012CN101810574B Method for preparing stable docetaxel submicron emulsion injection and freeze-dried emulsion
06/27/2012CN101808668B Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
06/27/2012CN101791363B Broad spectrum anticancer vegetable drug, preparation method and application thereof
06/27/2012CN101791332B Compound gingko health product solid preparation
06/27/2012CN101780066B Usage of isothiocyanate in preparing medicine for preventing from tumor invasion and metastasis
06/27/2012CN101780043B Preparation method of sanguinarine liposome with acid sensitivity
06/27/2012CN101775082B Amphoteric ion-based charge reversal chitosan derivative and application thereof in medicament
06/27/2012CN101747404B Glycyrrhetinic acid cyclic phosphonate ester derivative and preparation method thereof
06/27/2012CN101747382B Ruthenium polypyridyl complex using quinolones compound as ligand, preparation method and application thereof
06/27/2012CN101724074B Humanized chimeric antibody of angiostatin receptor beta subunit, preparation thereof and application thereof
06/27/2012CN101715453B Heterocyclic compounds and their uses
06/27/2012CN101704872B 23-hydroxybetulinic acid derivatives as well as preparation methods and application thereof
06/27/2012CN101679446B 3,3-spiroindolinone derivatives
06/27/2012CN101671278B Carbamic acid alkannin ester as well as preparation method and application thereof
06/27/2012CN101613679B Rhabdovirus with recombination superoxide dismutase gene and preparation and application thereof
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101516860B Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors
06/27/2012CN101513390B Hydrochloric acid boanmycin liposomes and preparation method thereof
06/27/2012CN101485885B Protein phosphatase PPM1E used as target for treating disease as well as use thereof and siRNA
06/27/2012CN101463060B 通关藤提取物 Marsdenia extract
06/27/2012CN101460623B Novel anti-CD98 antibody
06/27/2012CN101445554B Wood frog anticancer peptide and preparation method thereof
06/27/2012CN101439050B Medicament for treating malignancy and production method
06/27/2012CN101397274B Novel natural imidazole formic acid derivates, preparation method and use thereof
06/27/2012CN101366831B Rhubarb polyoses, preparation method, medicament composition and uses
06/27/2012CN101353339B Synthesis of quercetin platinum
06/27/2012CN101352418B Pirarubicin or pirarubicin hydrochloride lipid nano granule and preparation method thereof
06/27/2012CN101347518B Effective component of red paeonia and preparation and use thereof
06/27/2012CN101333196B 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/27/2012CN101291934B Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
06/27/2012CN101238876B Health seasoning for pre--cancer-chemotherapy
06/27/2012CN101233911B Health seasoning for post-cancer-chemotherapy
06/27/2012CN101233156B Cd19 antibodies and their uses
06/27/2012CN101156674B A cancer prevention flavoring
06/27/2012CN101133786B Wilding synthesized barley granules orange juice and method of processing the same
06/26/2012USRE43497 Anti-MIF antibodies
06/26/2012US8209131 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules
06/26/2012US8207326 Identification of novel genes coding for small temporal RNAs
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207177 Inhibitors of E1 activating enzymes
06/26/2012US8207152 Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling
06/26/2012US8207142 Inhibitor of DNA methylation
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8207123 Tumour-specific animal proteins
06/26/2012US8207122 Anti-cancer bioactive peptides isolated from crude venom of Xinjiang Lycosa singoriensis
06/26/2012US8207121 Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206727 Oral suspension of prednisolone acetate
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206711 Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206704 Use of GCC ligands
06/26/2012US8206701 Human leukocyte antigen (HLA); into which proteins and/or peptides or RNA or DNA or cDNA encoding the proteins and/or peptides which are overexpressed in tumor cells or which are derived from tumor cells have been introduced
06/26/2012CA2648518C Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor
06/26/2012CA2635093C Derivatives of sulindac, use thereof and preparation thereof
06/26/2012CA2603810C Potentiator for radiation therapy comprising pyridine derivative as active ingredient
06/26/2012CA2536185C Drug delivery system by administrating fine particles to sub-tenon
06/26/2012CA2472581C Tricyclic-bis-enone derivatives and methods of use thereof
06/26/2012CA2445875C Pentapeptide compounds and uses related thereto
06/26/2012CA2443857C Bisphosphonate conjugates and methods of making and using the same
06/26/2012CA2426952C Small molecule compositions for binding to hsp90
06/26/2012CA2425602C Methods of high-throughput screening for internalizing antibodies
06/26/2012CA2220021C Biologically active peptides and compositions, their use
06/21/2012WO2012083246A1 Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
06/21/2012WO2012083197A1 Water-soluble polymer conjugates of topotecan
06/21/2012WO2012083153A1 Oligomer-containing apremilast moiety compounds
06/21/2012WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors
06/21/2012WO2012082997A1 Tricyclic pi3k inhibitor compounds and methods of use
06/21/2012WO2012082972A1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
06/21/2012WO2012082862A2 Androgen receptor inhibitors and methods of use thereof
06/21/2012WO2012082841A2 Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
06/21/2012WO2012082752A2 Anti-ccl25 and anti-ccr9 antibodies for the prevention and treatment of cancer and cancer cell migration
06/21/2012WO2012082689A1 SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
06/21/2012WO2012082470A2 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
06/21/2012WO2012082436A2 Modulators of histone methyltransferase, and methods of use thereof
06/21/2012WO2012081711A1 Cell migration modulator
06/21/2012WO2012081531A1 Disease inhibiting agent
06/21/2012WO2012081273A1 Disease inhibiting agent
06/21/2012WO2012081022A1 Anthraquinones for use as radiosensitizers in cancer treatment
06/21/2012WO2012081017A1 Compositions and methods for treating cancer and neurodegenerative diseases
06/21/2012WO2012080990A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
06/21/2012WO2012080976A1 Lar protein-specific ligand
06/21/2012WO2012080703A1 Pharmaceutical composition comprising imatinib
06/21/2012WO2012080642A1 Use of an antibody directed against a membrane protein
06/21/2012WO2012080509A1 Nucleic acids targeting tctp for use in the treatment of chemo-or hormone-resistant cancers
06/21/2012WO2012080457A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
06/21/2012WO2012080389A1 Combination therapy of an afucosylated cd20 antibody with a mdm2 inhibitor
06/21/2012WO2012080271A1 Dimeric iap inhibitors
06/21/2012WO2012080260A1 Dimeric iap inhibitors
06/21/2012WO2012080237A1 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 2211